Want to join the conversation?
Drug maker $LCI reported record net sales for 4Q16 and FY16. The thyroid deficiency category generated record net sales of $45.9MM. Company benefited from the first full quarter of sales of clarithromycin, which it distributes for its Chinese alliance partner, ATC.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?